General Information of Target

Target ID LDTP09911
Target Name Kallikrein-6 (KLK6)
Gene Name KLK6
Gene ID 5653
Synonyms
PRSS18; PRSS9; Kallikrein-6; EC 3.4.21.-; Neurosin; Protease M; SP59; Serine protease 18; Serine protease 9; Zyme
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Sequence
MGGPRALLAALWALEAAGTAALRIGAFNIQSFGDSKVSDPACGSIIAKILAGYDLALVQE
VRDPDLSAVSALMEQINSVSEHEYSFVSSQPLGRDQYKEMYLFVYRKDAVSVVDTYLYPD
PEDVFSREPFVVKFSAPGTGERAPPLPSRRALTPPPLPAAAQNLVLIPLHAAPHQAVAEI
DALYDVYLDVIDKWGTDDMLFLGDFNADCSYVRAQDWAAIRLRSSEVFKWLIPDSADTTV
GNSDCAYDRIVACGARLRRSLKPQSATVHDFQEEFGLDQTQALAISDHFPVEVTLKFHR
Target Type
Literature-reported
Target Bioclass
Enzyme
Family
Peptidase S1 family, Kallikrein subfamily
Subcellular location
Secreted
Function
Serine protease which exhibits a preference for Arg over Lys in the substrate P1 position and for Ser or Pro in the P2 position. Shows activity against amyloid precursor protein, myelin basic protein, gelatin, casein and extracellular matrix proteins such as fibronectin, laminin, vitronectin and collagen. Degrades alpha-synuclein and prevents its polymerization, indicating that it may be involved in the pathogenesis of Parkinson disease and other synucleinopathies. May be involved in regulation of axon outgrowth following spinal cord injury. Tumor cells treated with a neutralizing KLK6 antibody migrate less than control cells, suggesting a role in invasion and metastasis.
TTD ID
T53612
Uniprot ID
Q92876
DrugMap ID
TTLPF4X
Ensemble ID
ENST00000310157.7
HGNC ID
HGNC:6367
ChEMBL ID
CHEMBL4448

Target Site Mutations in Different Cell Lines

Cell line Mutation details Probe for labeling this protein in this cell
KYSE150 SNV: p.L51H .
NCIH1944 SNV: p.H103N .
NCIH2170 SNV: p.Q105H .
NCIH446 SNV: p.H206P .
SUIT2 SNV: p.I237V .

Probe(s) Labeling This Target

ABPP Probe
Click To Hide/Show 1 Probe Related to This Target
Probe name Structure Binding Site(Ratio) Interaction ID Ref
DBIA
 Probe Info 
C218(1.51)  LDD3360  [1]

Competitor(s) Related to This Target

Competitor ID Name Cell line Binding Site(Ratio) Interaction ID Ref
 LDCM0022  KB02 AGS C28(1.45)  LDD2263  [1]
 LDCM0023  KB03 AGS C28(1.32)  LDD2680  [1]
 LDCM0024  KB05 NCI-H3122 C218(1.51)  LDD3360  [1]

References

1 DrugMap: A quantitative pan-cancer analysis of cysteine ligandability. Cell. 2024 May 9;187(10):2536-2556.e30. doi: 10.1016/j.cell.2024.03.027. Epub 2024 Apr 22.
Mass spectrometry data entry: PXD047840